Maloney And Clyburn Launch Investigation Into Emergent BioSolutions’ Profits And Performance Under Federal Vaccine Contracts

April 19, 2021

Select Subcommittee Announces Hearing and Seeks Testimony from Top Emergent Executives

Letter to Mr. Robert G. Kramer, President and CEO, Emergent Biosolutions, Inc., and Mr. Fuad El-Hibri, Executive Chairman, Emergent BioSolutions, Inc. [PDF]